E Holme
Impact in
- Clinical Biochemistry top 10%
- Metabolism and Genetic Disorders
-
- Complement system in diseases
Papers in
-
- T-cell and B-cell Immunology 3
- Complement system in diseases 3
- Co-authors
- K Whaley (11 shared papers)Jennifer A. Veitch (7 shared papers)Asad Zoma (4 shared papers)Alistair I. Fyfe (3 shared papers)M. Tulinius (2 shared papers)Anders Oldfors (2 shared papers)Niklas Darín (2 shared papers)A. David Burden (1 shared paper)
- Journals
- European Heart Journal (2 papers)Neuropediatrics (2 papers)Pediatric Nephrology (1 paper)Hepatology (1 paper)Clinical & Experimental Immunology (1 paper)
- Partner nations
- United KingdomSwedenUnited States
In The Last Decade
E Holme
26 papers receiving 348 citations
Peers
Comparison fields: 5 of 63
- Clinical Biochemistry 45
- Immunology 128
- Nephrology 41
- Rheumatology 85
- Hematology 51
Countries citing papers authored by E Holme
This map shows the geographic impact of E Holme's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E Holme with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E Holme more than expected).
Fields of papers citing papers by E Holme
This network shows the impact of papers produced by E Holme. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E Holme. The network helps show where E Holme may publish in the future.
Co-authors
The 25 scholars most cited alongside E Holme, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 28 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Decreased C3b receptors (CR1) on erythrocytes from patients with systemic lupus erythematosus. | 1986 | 41 |
| 2 | 2015 | 30 | |
| 3 | 2008 | 29 | |
| 4 | 2003 | 27 | |
| 5 | 1997 | 24 | |
| 6 | 1999 | 22 | |
| 7 | 1982 | 21 | |
| 8 | 1996 | 19 | |
| 9 | Prevention of immune precipitation by purified components of the alternative pathway. | 1985 | 19 |
| 10 | C3b receptor (CR1) expression on the polymorphonuclear leukocytes from patients with systemic lupus erythematosus. | 1987 | 18 |
| 11 | Familial properdin deficiency associated with chronic discoid lupus erythematosus. | 1989 | 17 |
| 12 | 2001 | 15 | |
| 13 | 1990 | 14 | |
| 14 | 1988 | 13 | |
| 15 | 2021 | 10 | |
| 16 | 1996 | 9 | |
| 17 | 1990 | 8 | |
| 18 | 1992 | 5 | |
| 19 | Antibodies to lactoferrin. A possible link between cow's milk intolerance and autoimmune disease. | 1998 | 4 |
| 20 | 1995 | 3 |
About E Holme
E Holme is a scholar working on Immunology, Molecular Biology, Rheumatology, Radiology, Nuclear Medicine and Imaging and Clinical Biochemistry, having authored 28 papers that have together received 360 indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (7 papers), Systemic Lupus Erythematosus Research (6 papers), Metabolism and Genetic Disorders (4 papers), T-cell and B-cell Immunology (3 papers), Complement system in diseases (3 papers), Diabetes and associated disorders (2 papers), Vasculitis and related conditions (2 papers) and Amino Acid Enzymes and Metabolism (2 papers). The work is most often cited by research in Clinical Biochemistry (45 citations), Immunology (128 citations), Nephrology (41 citations), Rheumatology (85 citations) and Hematology (51 citations). E Holme has collaborated with scholars based in United Kingdom, Sweden and United States. Frequent co-authors include K Whaley, Jennifer A. Veitch, Asad Zoma, Alistair I. Fyfe, M. Tulinius, Anders Oldfors, Niklas Darín, A. David Burden, R. John Aitken and Joyce Davidson. Their work appears in journals such as European Heart Journal, Neuropediatrics, Pediatric Nephrology, Hepatology and Clinical & Experimental Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.